Dr Stock Pick HOT News & Alerts!

_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Wednesday September 30, 2009

DrStockPick.com Stock Report!

PWRM, ATU, AQNM, DSCO, TSTR, CHIP

**************************************************************

PWRM, Power 3 Medical Products Inc, PWRM.OB

Power3 Medical Products, Inc. is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). Power3 expects to complete phase II clinical validation trials of its blood serum diagnostics for Alzheimer’s disease (NuroPro-AD), and Parkinson’s disease (NuroPro-PD) in 2009 and for breast cancer in 2010, followed by filings with the FDA. Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas. Power3 continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS, Alzheimer’s, and Parkinson’s diseases, and breast cancer.

PWRM Announced that its Chief Scientific Officer is Chair and Keynote Speaker of Session at the BTI Life Sciences 2nd Annual Congress and Expo of Molecular Diagnostics in Beijing, China in November 2009

Further international recognition of validity as the company’s President and CSO, Dr. Ira Goldknopf will deliver an invited Keynote address and chair a session on “Biomarkers and Diagnostics in Personalized Medicine (Track 6-4),” at the BIT Life Sciences 2nd International Congress and Expo of Molecular Diagnostics in Beijing, China, November 19-21, 2009. The Theme of the meeting is “New Leadership of Personalized Medicine.”

More about PWRM at www.power3medical.com

**************************************************************

ATU, Actuant Corporation

ATU manufactures industrial products and systems worldwide. It operates in four segments: Industrial, Electrical, Actuation Systems, and Engineered Products.

ATU today announced sales and earnings for its fourth quarter and fiscal year ended August 31, 2009.

**************************************************************

DSCO, Discovery Laboratories Inc.

DSCO is a biotechnology company developing Surfactant Therapies for respiratory diseases. Surfactants are produced naturally in the lungs and are essential for breathing. DSCO’s novel proprietary KL4 Surfactant Technology produces a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant and is being developed in liquid, aerosol or lyophilized formulations.

DSCO held a teleconference on September 29, 2009 with the U.S. Food and Drug Administration (FDA). The meeting established an approach to potentially resolve the remaining primary issue that DSCO must address to gain U.S. marketing approval of Surfaxin(R) (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants. The meeting focused on Discovery Labs’ plans regarding optimization and final method validation of its fetal rabbit Biological Activity Test (BAT, a quality control and stability release test) and a proposed limited Surfaxin clinical trial design, which would simultaneously employ the newly-optimized BAT.

**************************************************************

TSTR, TerreStar Corporation

TSTR through its subsidiaries, engages in the integrated satellite wireless communications business in North America. The company, through its subsidiary, TerreStar Networks Inc., intends to build, own, and operate an Internet protocol based integrated satellite and terrestrial communications network to provide mobile communication services in the United States and Canada.

AT&T Inc. plans to sell a satellite phone from TSTR that can place calls even in the deep wilderness or at sea.

**************************************************************

AQNM, Aquentium, Inc., AQNM.OB

Aquentium, Inc. (OTCBB: AQNM) a publicly traded company with a focus on “green technologies” is pleased to announce that the company’s non-chemical technology sanitizes fruits and vegetables naturally without the use of any chemicals.

The Aquentium non-chemical sanitation equipment is designed for improved food safety standards both domestically and internationally. Aquentium is currently offering exclusive representation opportunities for its complete line of non-chemical processing and sanitation equipment for fruits and vegetables in countries throughout the world as well in all fifty states in the USA

The goal at Aquentium is to help prevent contamination of fresh fruits and vegetables. The Aquentium non-chemical process can extend the shelf life of produce which means higher profits for food processors and less waste for the consumer.

The uniqueness of the Aquentium technology is that it is over 50% more effective than chemicals and over 3,000 times faster acting than chemicals. Ultimately, Aquentium believes that we have better technology to combat e-coli, salmonella, listeria and other bacteria or viruses than what most food processors are currently using.

With the Aquentium equipment, a processor does not have to stop processing to do plant sanitation. This increases plant production. Furthermore, food processors can expect an ROI in less than 12 months using the Aquentium equipment.

More about AQNM at www.aquentium.com

**************************************************************

CHIP, VeriChip Corporation

CHIP has developed the VeriMed™ Health Link System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip and corresponding personal health record, cleared for medical use in October 2004 by the United States Food and Drug Administration.

CHIP and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip. In Phase II of this program, which is expected to be completed in the second quarter of 2010, the critical binding environment and competitor agent components of the glucose sensor will be optimized for system stability, sensitivity and specificity.

**************************************************************

Keep a close eye on PWRM, ATU, AQNM, DSCO, TSTR and CHIP, do your homework, and like always BE READY for the ACTION!

***********Advertisement***********

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com End Of day publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.

Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick Stock Watch report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services for Power 3 Medical Products Inc. (PWRM.OB). Aquentium (AQNM) is paying 100,000 restricted shares to Crown Equity Holdings for public relations services.

_______________________________________________________

_______________________________________________________

Dr. Stock Pick

is a seasoned equity trader and financial investor. He’s on the Crown Equity Holdings, Inc (CRWE.OB) financial staff as a professional investment analyst and consultant. He’s syndicated on over 1000 websites www.crwenews.com, www.stock-ir.com giving daily, up to the minute information about stocks, options, currencies and more. www.drstockpick.com

email: investor@drstockpick.com

Dr Stock Pick would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com

Last 5 posts by Dr. Stock Pick

• DrStockPick.com Stock Report! Most Active Stocks Wednesday Nov 25, 2009 - November 25th, 2009
• PSFT, HZHI, CVAT, PWRM, HCEI, TAXS, CSRH, AQNM, Stocks at a Glance. DrStockPick.com Report! - November 25th, 2009
• DrStockPick.com Stock Report! 11/25/09, JPM, PSFT, SCOR, WWPW, HON, GTWO - November 25th, 2009
• HCEI, Healthy Coffee International Projects Seven Figure per Month Sales by November 2010 - November 25th, 2009
• HZHI, Exclusive Agreement With Exmovere Holdings Inc., for Mobility Aid and BioSensor Products is Opening the Door to a Multi Million Dollar Industry for Horizon Health International - November 25th, 2009